throbber
VOL. 215 NOS. 1-2
`
`14 MARCH 2001
`
`ISSN 0378-5173
`215 (1-2) 1-276 (2001)
`
`Univ. or Minn.
`Bio-Medical
`library
`
`
`
`Bass and Spangenberg
`v.
`Fresenius Kabi USA, LLC
`U.S. Patent No. 8,476,010
`Exhibit 1009
`
`

`
`~i 200 I Elsevier Science B. V. All rights reserved
`.
`•
`Thi~ journal and the indiVidual contributions contained in it arc protected by the copyright of Elsevtcr Sctence
`following terms and conditions apply tu their usc;
`
`13 v <1nd the
`· ·•
`
`f he publisher
`.
`.
`Photocopying
`Single photocopies of smgle articles may be made for personal use as allowed by national copyright la~vs. Pcrm~sston °. ~ t'sing or
`and payment of u fcc i, required for all other photocopying, including multiple or systematic copymg .. coPY1!1& ~or .'1 n:e~l:at wish
`promotional purpose). rc'Xtlc, and all forms of document delivery. Special ra tes lire avuilablc for cducauomtl msutuuo
`10 make photocoptc\ for non-profit educational classroom u::.e.
`.
`.
`.
`.
`.
`X UK: phone:
`Permtsstons may be \ought dm.:ctly fr?m Elscvter Sct~nce Gl~b<~l Rtghh ~cpartmcnt. PO Box 800. Oxford OXS ~ D
`·i hb direct!)'
`( + 44) 1865 843830. fax: ( + 44) 186) 853333, e-matl: pcrmtsstonslfuclsevter.co.uk. You muy al-.o contact Glob.tl R £
`.
`through Lhcvicr\ homepage (http:,fwww.cbevicr.nl), by selecting 'Obtaining Permissions'.
`od o nvc.
`In the USA. u-.er; may clear permissions and make payments through the Copyright Clearance Center, Inc .. 22~ Ro~ero Licen~ing
`
`Danvers. MA 01923, USA: phone: (+ I) (978) 7508400. fux: (+I )(978) 7504744. and in the UK through the Copyng 1
`5555: fal':
`Agency Rupid Cle<trance Service CCLARCS), 90 Tottenhnm Court Road, London WIP OLP. UK: phone: (+44 ) 207 63
`( + 44) 207 63 1 5500. Other countrie · may have a local reprographic rights agency l'or payments.
`
`11
`
`within du:ir
`
`Ocrivath•c Work'>
`Subscribers mily reproduce tnbles of contents or prepare lbts of article~ including ahstracts !'or internal circulation
`institutiou'l. (>crmi~~ion of the t>ublisher is required l'l)r resale or distributiou out~ide the inslitutiou.
`Permi,~ion of the publh.her i' required for all other derivative works, including compilations and translation-..
`. rticle or
`Electronic Stont:.:e or
`' " I:C
`.
`1
`J>enni .. ~ion of the Publisher is required to store or usc electronically any material contained 111 this journal. includmg any '
`part of an article.
`1
`. d ·n ·tnY foro
`Except "'outlined above. no P<trl of thio; public:cttion may be reproduced. o;torcd in a retrieval sy,tcm or tr.an.sm•ttc ~ 'ublishcr.
`or by any mc<tn-.. electronic, mechanical, photocopying, recording or otherwi~c. without prior written pcrmtsston of 1 c p • bo'-.:.
`·1 ddre·scs noted '1
`Addtc:.:. penni:.~ion:. teque~t~ to: Ebcvicr S~.;icncc Glob<tl Righb Dcp.u tmcnt. ill the m<ul, fax und c-m:u ' 1
`s

`, . Jiabilit)'·
`~oticc
`1o ~espothibility is a~\umcd by the Publisher for un~ injury und/or damage to pero;o~o; or p~opcrty '!sa m<~tter. ?f pr<_>du1~1t: nullcri<tl
`neghgcncc or othcrwt-.c, or from any u~c or operation of any methods. product\, m~trucuon:. or tdeas cont.uned 111d
`doS<Ig.::~
`herein. Because of rapid advances in the medical sciences. in particular. independent verification of diagnoses and
`rug
`should be made.
`1 · public·ttion docs not
`· 1 •


`d
`· I ·
`· ·
`•
`to conform to etlucal lmedtcal) .,tandards. me uston m I us
`tloug n n vertt~mg matcn a
`r.1cwrcr.
`· . •
`ts expcctc
`II d
`AI I
`h
`'

`f ' t by tiS manU~<
`.
`f
`.
`d
`constitute a guarantee or endorsement o the qualny or value of such product or or the cluum ma e o
`'
`· M · Tino de Carlo. TJ~,;)'
`A·'
`· · 1 f
`be
`· ·
`d
`d
`· ·
`· Ad
`. ( + 1) (21 ~
`,.uvcrttsmg n ormation. " vcrusmg or crs an cnqumes can
`se111 to: USA, Canadn and South Amcn ca:
`•
`.
`Advertising Department. Elsevier Scicne~ Inc., 655 Avenue of the Americas, New York. NY 10010-5107. US(':~~~·~"~·. K.K .. 9-15
`633 381 5; fm<.: ( t I) (2 12) 633 3820; c-tmul: l.dcc<~rlo((_yelscvicr.com. J ltpun: The Advertising Department, Elsevmcr Sctencc [ rope und
`Higashi-Ac:abu 1-chome. Minato-ku. Tokyo 106-0044. Japan: phone: (+81) (3) 5561 5033; l'ax: (+8 1) (3) 5561 5047· ~~~dlin~toll·
`1
`!lOW: Ruche! ~eveson-Gower, The Advertising Department. Elsevier Science Ltd .. The Boulevurd, Langfo:d .L:ule. tk
`Oxford OX5 I GB. UK; phone.: ( + 44) ( 1865) 843565: fax: ( +44) ( 1865) 843976: e-m<til: r.lcvcson-gower(~elscvtet.cO.l
`
`Order~. clnim~ :unl product cntluiric-.: plcao;c eonlacl the Cu,lomcr Support Department al the Rc~;ronul Sai~"S Office nc;trcsl you:
`· .. 111
`h Am~r•''
`.
`" c" York: Elo;cvicr Science. PO Dux 945. New York. NY 10159-0945. USA: phone ( I- I) (212) 6:133710 [toll free number lor Norl
`cu,tomcr' 1-RKII-4E.'i-I NI 0 (437-4636)): rax: ( ~ I) (212) 6333680: e-mail: usinfo-rfa·clo;cvtcr.com
`Am, tcrtlam: l::.l!~<!vtcr Scu:ncc. 1'0 Box 211. 1000 AE Amsterdam. T he Netherland$; phone· ( + 31) 20 41153757: fuJ.: ( + 31) 20
`nhnfo-ffit clscvi.:r nl
`'l nl.) n: U!~<!vtcr Science. 9-15 lliga:.hi-Az;tbu 1-chomc. Min:uo-ku. Tokyo 1()(,-(1().14, Jap;lll~ phon.:.: ( + KI) (3) 5561 5033: f;t~ ( + 81) (:1)
`1
`c-m:ul mfoli• d-.c\ rcr ;;o.Jp
`'7 ?2)0: c-rll•ll .
`S inJ.::Ipore: Llsc\tcr Sc1cncc. No I Tcnm-.ck Av.:nuo:. ;;. 17-0t Mtllcntot To,~cr. Singapore OWI92: phone: ( .. 65) 434 3727: rax: I +65) ),> -
`a'hllllfUftl ci\C\ i<:r.CIIlll.,j;
`.
`,
`.
`14()· oO'
`ltio de .Jnnciro: Fbevrcr Scrcn;;c. R ua Sctc de S..:l.:mbr\1 Ill 1(, Andar. 2005()-()()2 {\:mm. Roo de Janc1ro RJ. Hr.tzil: phone. I+ 55) (21 l 5(~) .'R..:L!i<>tl•11
`1 1
`( -;- 55) 121) 507 I WI . c-mml d...:' icrft• c;tmpu,.com.br JNolc (U1tin Amcrie<t): for order:.. claim~ ,md hdp dc'k mfornmtion. pka...: contact
`"
`Sak.., Otlicc 111 No:" York "' Ji,tcd above)
`
`48534
`
`,, 'tll•lil'
`·-: ~·
`I 5()-11.
`5
`1
`5(
`
`VJ The paper u'cd in thi' publication meets thc requirement~ of ANSI/NISO Z39.48-1992 (Permanence of Paper)
`
`Printed 111 the Uni!cd Kin~dom
`
`Exh. 1009
`
`-
`
`

`
`I ntcrnatio n;ll Journal of Pharmm:cutic!> 215 CWO I) :!()7 2:!0
`
`international
`journal of
`pharmaceutics
`111111 .d..c1 tcr.Ctllll kx:;ttc ijphann
`
`Physical properties and stability of two emulsion
`fonnulations of propofol
`
`Jiho ng Ha n, Stanley S. Davis, C tive W ashin gton *
`
`.<:du111f 11/ l'llm·nlm·r•lftiml Srh•m·r•,\, Uuil'l'rsit,l' of Nu11inglw111. Uuir·r·rsity !'ark. Nollim.dunu. N(i7 :JRJ) Ul\
`Rccctvcd 0 I Ocwbcr 2000: r..:cdv..:d in rcvi~..:d form :!R Nowmhcr :!000: accepted 05 Dc..:cmhcr :wno
`
`\Vc have t:<lmparetl the phy'iical propcrtic:-. of two ~.:ommercial emulo.;ion formulation~ of the intrav..:nuus anaesthetic
`propofol. (l)ipri\'an • . 1\straZenc~.:a. and Propofol Intravenous l: mubion. Gen~ia Sieor Pharmac..:uticals) which appear
`10 tlillcr primarily in the additive conte111 and formulation pi I. Dipril'an • contains di-;otlium ctktatc and ha-; a pi I
`or 7 8.5. whit..: the Gen-.ia protlm:t contains S(}c.lium metabisulphite and is rormulatec.llll a pH or 4.5 (l.-1. Th..: alerage
`zeta potential of Oipriv;m• at pll 8 was - 50 mV while that of the Gen~m product at pH 4 5 was - -HlmV. Thi:-.
`information -;uggcsh that the physical stab11it) or Proporol lntntvcnOll'> l:.muhion :-.hould be lower than that of
`Diprivun •. Three random be~tt:hcs or both product:-. were ~ubjectcd to u range or \lability tesh. including shaking.
`thaw t:ycling. and the emulsion droplct 'i1..: c.lisuibution wa~ then a:-.:-.e:-.scc.l by dynamic
`thermal cycling. anc.l freeze
`light scaltering. light diffraction. ami electrical anc.l optical LOne sensing. !3oth emubi~lth initially showed narnm
`:.ubmicrometrc particle size distributions. An increased levd ~ll' droplets larger tiHtn S pm could be detected in
`Propofol l ntravenou~ bnulsion after a~ liule <IS 4 h shaking (300 -;trokc:. min at room ll.:mpcrature) and l'i:.iblc l'rce
`oil could be detected after 8 12 h shaking. In contrast. Oiprivan'' ~howell no increase in the large droplet ~.:ount after
`shak ing !'or time-. up to 16 h. A similar tlilTerence in the emul-.ions was found al'ler one freeze thaw cycle. with
`Propol'ol Intravenous Emulsion exhibiting extensive ~.:oalesccnce. while that or Diprivan'' was at the limits or
`detection. We ~.:ondude that these two pro~lucts have tliiTercnt physi<:al stability chantctcri~tks. and t hat this may in
`part be due lO the rec.luced zeta potential in Propol'ol Intravenous Emulsion compared to that or Diprivan'' . !'I 2001
`Published by Elsevier Science 13. V.
`
`Kr•yH·orck J>rnpofol: Dipriv;111 ' : Emul~ion: Stability
`
`• Curn.:,pundmg. author. I cl.: 1 ..J-1-11 "i-')S I 5():;\..J: J'ax: -t 4-J.
`115-951 'i I 0:!.
`L'-111wl mldrr·" : clivc.\\l"hin!,:tlmla nottingham.ac.uk !C'.
`wa,hingtun).
`
`I. Introduction
`
`Propofol (2.6 di-isopropylphcnol) is a widely
`ll!\~<.1 intr<I\CilOUs iliHIC~thctic (Glen and H unter,
`1984: Co~.:b,hou ct al.. 1990. 1991). Like many
`anaest hetics. propofol is hydrophobic. having a
`calculated partition cocl'fkicnt ( Log P, . .,1,.) of :un
`
`0~78-51 7:\ 01 "i- 'cc J'nmt mutter 1 20()1 Published by El~..:vicr Science B.V.
`I'll: SOJ7X - 51 7 )(()0)00Cl92 - X
`
`Exh. 1009
`
`

`
`208
`
`.1. !11111 1'1 a/.
`
`lnremmimml .Jmmmlof Plmrmacl!/1/ic.~ 1 15 (1001) 107 210
`
`and it presents lillie o pportunity for solubilization
`through salt formation. As a result it is formu(cid:173)
`lated as an oil-it1-water emulsion ( Diprivan ", As(cid:173)
`rraZeneca). in which the disperse phase is soya oil
`containing dissolved pro pofol. emulsified using
`lecithin. and having a mean droplet size of 150 -
`200 nm (VMD).
`Emulsions intended for intravenous use should
`have an extremely sma ll dro plet size .and be highly
`sta ble. since a ny large dro plets placed in the circu(cid:173)
`la tion nuay lodge in the pulmona ry capillaries a nd
`could potentially lead to an embolism (I lium ct
`al.. 1982). The exact size at which this phe(cid:173)
`nomeno n becomes importctnt is widely deba ted
`and pha rmacopoeia l limits on particulates in par-
`
`enterals a re vague. a lthough 5 pm is generally
`accepted as an upper limit. Oiprivan "', and intra(cid:173)
`venous feeding emulsions such as lntralipid. have
`p~u·ticle sizes much smaller
`than
`this. mean
`dro plet diameters being of the order of I 00-300
`nm. However. the systems a rc significa ntly poly(cid:173)
`disperse. and dro plet counting techniques can de(cid:173)
`tect a small nllln ber of pa nicles larger than I ~tm
`in the formulations. It is also evident that such
`emulsions must be formula ted with adequate
`ph ysical stability to prevent the droplet size distri(cid:173)
`bution evolving during the sto rage lifetime, and
`exceeding clinica lly sarc limits.
`Intravenous emulsions such HS Dipri van " arc
`stabilized with phospholi pids
`in
`the rorm of
`
`Naked Eye Inspectio n
`
`Microscopy
`
`Optical Couming
`
`Light Diffraction
`
`Electrical Zone Sensing
`
`Dynamic Light Scattering
`
`I~ JQ·K
`
`J0·7
`
`10·6
`
`IQ·S
`
`LQ-4
`
`JQ·3
`
`J0·2
`
`Fig. I. S..:nsitivity range~ or the panid..: charactcritalion techniques used in this study (exact values oepcnu on spccillc instrumcm)
`anti the sit.e distribution or" typical imravcnou~ emulsion.
`
`Size (m)
`
`Table I
`Properties OJ' Ull~trcsscd emulsion~
`
`l'mdm:l
`
`13atch Ill.~.
`
`Volume mean diamch.:r ( I)LS). nm
`pll
`Droplet count number > SJ•m ~~~ (Coulter Z2l
`
`Ditwivan"
`
`Propol'ol intl'avcnou~ cmubion
`
`Ull40 B
`
`K &179/A
`
`X91)151A
`
`99~~() 1
`
`991..:309
`
`99 1.:D I 2
`
`171 ± 2
`7.6
`120
`
`177 ± I
`7.5
`200
`- -
`
`172±2
`7.5
`160
`
`17tl± I
`5. 1
`J()()
`
`184 ± I
`5.5
`:100
`
`178± I
`5.6
`220
`
`Exh. 1009
`
`

`
`.1. Htm et a/.
`
`f11temational .loumalo( Pltamtllt'<•tttic-,· 215 (200 I ) 2117 :!10
`
`209
`
`Zeta potential (mV)
`
`Propof'Jl lnrr:.venous
`Ermtlston 1>H range
`
`Dtpnvan®pHrange
`
`0
`
`-10
`
`·20
`
`-30
`
`-40
`
`-50
`
`-60 ~----~------+------+------+------+------+------+----~
`4D
`2D
`SD
`7D
`3D
`SD
`6.0
`9.0
`10.0
`
`pH
`
`Fil!. 2. Zeta pmcntials or o.:mulsinn~ as a runclion or pi I. Closo.:u symbols: D iprivan • (thn:o.: bntch.:s). opcn symbol~. Propnl'nl
`ln~ra vcnous Emulsion (lhrco.: batchcs).
`
`z-avera ge
`diameter (nm)
`220
`
`Free Oil Free Oil
`
`Free Oil
`
`140 +-----r---~-----+----~----+-----r---~----~
`12
`10
`14
`16
`8
`6
`2
`4
`0
`Shaking time (hour)
`
`Fig. 3. :-avcragc dian1<:1o.:r or ..:mulsions by DLS as a !'unction or sh;1king tim.:. Closed symbok l)iprivan • (llm:o.: h;ncho.:~): 1.\p..:n
`symbols. l'mpo fol Intravenous Emul~ion (lhrO.:l' batc.:h..:s).
`
`Exh. 1009
`
`

`
`210
`
`.!. Han et af. / lllfemmirmal .!oumal IJ( Plwmwceutic.v 115 (1001) 10 7- 210
`
`puri fied egg lecithins. We and others have previ(cid:173)
`ously studied the stability or such emulsions in a
`number of pape1·s (Black and Popovich, 1981:
`
`Blllrnham et al.. 1983:
`1990,
`1991'
`1992:
`1992a.b. 1996) and
`
`Washington et al.. 1989.
`1990a,b.c.
`Washington.
`it
`i~ now well un-
`
`Counts/Ill, >5 J.lm
`
`2500
`
`Fig. 4. Count of larg.: droplets in emulsions by C'ouhcr Z2 a~ a function of ~hakin~ tim.:. Clo~cd symbpl~; DipriVilll " !IIH~:l· bill(,;hcs):
`open ~ym hol:;. J>ropofol Intravenous Emulsion (three batch.:~).
`
`Shaking time (hour)
`
`C oun t s/)..11,>5 )lm
`
`300 0
`
`Free Oin
`
`Fig. 5. Count of large droplets in emulsions by A ccusizcr 780 as a function o f shaking time. C losed symbols: Diprivan " (three
`batch.:s): open ~ymbols. l'ropofol Intravenous Emulsion (thr.:c batches).
`
`10
`Shaking tim e (hou r)
`
`12
`
`14
`
`16
`
`Exh. 1009
`
`

`
`J. lltm t•t a/.
`
`futt•rmaimwl Jn11ma/ o/' Plwrmun'llllc' 115 (21)()} J 207 220
`
`211
`
`Particle size (J.lm),
`<90%
`0.5
`
`0.3
`
`Free Oil
`
`0. 1 ~--~----~----~---+----+---~----~--~
`0
`2
`4
`6
`8
`10
`12
`1 4
`16
`Shaking time (h our)
`
`1-u!. 6. l)l)U of cmul~ll>ll~ by light c.Jill'ractiun by Coulter LSDO a~ a l'unclion ul 'hakmg time Cln...:d ,yml"K>I~: Diprh•an' (three
`ba~chc,): upcn ')mbok l'ropul'ol lntra\cnou' Emulsion (three batchc,).
`
`(a) 0 hours
`
`4hours
`
`8 hours
`
`(b) 0 hours
`
`4 hours
`
`8 hours
`
`Fig. 7 Pholtltnlcmgraph' or (a) Diprivan· anc.J (b) l'ropofl>l lntm\eii0\1'> Lmuhi\lll after II. 4 otnd ~ h .,hal.ing.
`
`tlcrstoo<.l that thc'c systems arc chargc-:>tabilized
`with a zeta potential of - 40 to - 50 mY at pll
`8. As a result. they show excellent stability in
`normal use. However, any !'actor which lowers the
`
`zeta potential may lead to instability and the
`resultant forma tion or large oil droplets. 1 mpor(cid:173)
`tant factor-; in thio; rega rd arc electro lytes and pi I
`(Washington. 1990b.c: Washingto n ct al.. 1993).
`
`Exh. 1009
`
`

`
`212
`
`J. /11111 t•/ ul.
`
`lntt•motional Joumul o/11/uii'J//IIt'l'lllil'.l' 2 I 5 (](}{)/} 207 220
`
`-u
`
`'-"
`
`Exh. 1009
`
`

`
`J. H1111 ''/ a/.
`
`lllt,•matiumd Jmmw/ td Phamlllt'('lltic.\ 115 (20(1/) 1/17 110
`
`The io niza tio n curve of lecithins reaches a point
`or zero charge (PZC) at approximately p i I 3 and
`conseqltenlly a lowering or p i I may reasonably
`be expected to lead to reduced physical st<tbility.
`Recently an alternative propo!'ol formulation
`to Dipriva n '' has appeared o n the U.S. market
`(Propofol Intravenous Emulsion. Gensia Sicor
`Pha rmaceuticals). This materia l is supe rficially
`similar to Diprivan '" in tha~ it consists or a soya
`o il based emulsion containing I 0 mg/ml propofol
`and having a mean droplet diameter or 150 200
`nm. Howeve r the formulation has a p ll in the
`range 4.5 6.4. necessary to ensu re the antimit:ro(cid:173)
`bial activity or its bisulphiuc additive. We would
`predict
`that.
`assuming
`that
`the
`let:ithin
`emulsi fiers are similar. this emulsion would show
`a different stability profile to that of' D ipri van "
`and therefore we have pe rformed a COlnprchen(cid:173)
`sive set of stability measurements to compare the
`two formulations. To assess the physical stability
`we used three widely accepted accelerated tests:
`
`shaking. freeze thaw cycling. and thermal cy(cid:173)
`cling. In order to measure properly the ef'f'ect
`that these processe:; had on the droplet size t.lis(cid:173)
`tribution it was necessary to usc a number or
`different particle size measurement
`techniques.
`The origi nal emulsions have na rrow size distribu(cid:173)
`tions which almost wholly lie below 1 pm. How(cid:173)
`ever after exposure to the accelen1ted stability
`test. the range or droplet sizes me~y potentially
`vary from hundreds or nanometrcs to millimc(cid:173)
`trcs. a span or lour orders or magnitude. Fig. I
`shows the measurement limits of the te<.:hniques
`used: it wi ll be readily apprcci<lled that a full
`asscssmcm requires :;cvera I d i rreren t measure(cid:173)
`ments. In particular it was lc lt that the Coulter
`Counter wus a n esscnti<tl technique since it pro(cid:173)
`vides droplet volume measurements. which arc
`traceable to primary standards. The remaining
`techniques arc all based on optical scatlcring and
`as a result may be sen siti ve to the optical prop(cid:173)
`erties or the emulsions.
`
`Particle s ize (nm)
`
`250
`
`200
`
`1 50+--------------+--------------+-------------~
`14
`2 1
`7
`0
`
`Dur ation (day)
`
`Fil!. 9. : ·avcraac diamctcr of cmubiotts by Dl.S a$ a !'unction ul' tlli.:rmal~.:~din!! tun..:. Chhed ..;ymbob: Dipri,an' (thrc..: batches):
`OJ~Il ~ymbol-;, -Prupul'ol ltHntvcnou~ Emul~ion (thrc..: bat~.:hc~l.
`
`Exh. 1009
`
`

`
`214
`
`J. I/ au t•t ol.
`
`lutematicmrtl Joumal u/ Pltw·mm·t·utic.~ 215 (2001) 207- 220
`
`Counts/J.LI, >5 ~m
`
`Fig. I 0 . Count of large droplet~ in .:mulsion ~ by Coulter Z2 il~ •• !'unction of thermal cycling time. Closed symbols: Diprivan • (three
`batdtcs): open ~ymbols. Prupol'ol Intravenous Emulsion (three batches).
`
`Duration (day)
`
`(a)
`
`(b)
`
`(c)
`
`(d)
`
`(e)
`
`(f)
`
`Fig. II. Phtllnmicrograph~ of l)iprivttn " Ca c) and l'rupol'ol lnt ravcntllt~ E:.mul~i<>n Cd
`
`I) after one freeze thaw cycle.
`
`Exh. 1009
`
`

`
`J. Jfau ('I a/.
`
`11111'/'1/alimw/ Joumal of' Pluii'J/Iacelrlics .215 (.200/) .207 1.20
`
`215
`
`2. Experimental section
`
`2.2. C/wroc t eri:m ion r I!CIIII iques
`
`2.1. Moll!riu/.1·
`
`Oiprivan '" (Batch nos. L8 140/ B. K8 179/A cmd
`X90 15/A) was supplied byAstraZeneca Mac(cid:173)
`clesfield (U K ). Propofo l Intravenous emu lsion
`(Batch nos. 99 E30 I. 99 E309. and 99 E3 12. Gensia
`Gensia Skor Pharmaceuticals. Irvine. California)
`was purc hased from material o n general sale in
`the U.S. T hree batches o f each fo rmula tio n were
`studied. Isotonic saline was p urchased fro m Beck(cid:173)
`man Coulter ( Luto n, UK). All ot he r chemicals
`used were purchased fro m Sigma Chemica l Com(cid:173)
`pany. Gillingham. UK. and were at leas t or A R
`grade. All materia ls were sto red in ac-cordance
`with the manufacturer's instructions.
`
`2.2. /. Zeta fU>fl!llliol
`Zeta po tentials were measured using a Malvern
`I nstrumcnts Zetasizer 4. which is based o n laser
`d o ppler velocimetry in an electric field. Values
`quoted are the average of fo ur measurements. The
`inst rument was va lida ted using the manufacturer's
`po lystyrene microsphere
`transfer
`standard
`(quoted -50 ±5 mV, measured
`- 46±2 mV)
`which is tracea ble to the
`1ST goe thite primary
`standard. The buffers used were: form ic acid/
`potassium hydroxide {pH 3.2): acetic acid/ potas(cid:173)
`sium hydrox ide (p H 4.3 and 5.3): potassium
`dihydrogcn phosphatc/diso dium hydrogen phos(cid:173)
`phate (pH 6.5 and 7.7) and boric acid/ borax (pH
`9.0). All buffers were made to estab)ished fonnu-
`
`511()
`
`~()()
`
`H ) ()
`
`:!!lll
`
`Jl)()
`
`I)
`
`I HI -111/B
`
`Kl! 17W,\
`
`X 'Jlll 5/ 1\
`
`')'l L~JO I
`
`991-:.30?
`
`'J'J J·:J 1:!
`
`Fig. 12. : -average \Jiamch:r or emulsions by DLS after one frcct.c 1haw cycle. Grcy bars: Diprivan ' (lhrcc batches): Fillc\.1 hars.
`J>ropofol l n1ravcnous Emu lsion (lhrcc balt:hcs).
`
`Exh. 1009
`
`

`
`(a)
`
`I
`10
`
`(b)
`
`10
`
`0.01
`
`0.1
`
`Volume (%)
`
`Diameter (J.UTI)
`
`().OJ
`
`Volume (%)
`
`0.1
`Oinmetcr (J.Lm)
`
`0.01
`
`0.1
`
`10
`
`Diameter (J.UTI)
`
`Fig. 1:1 . D rople t ~i/c di stribution~ !Coulter· LS23()} (a) u l"
`un~trc~~cd cmul~ion~: (h) after 6 h ~haking: and (c) al'tcr l lllC
`l'ri:c7c th;~w cycle. S(llid ~ymbok D iprivan " batch LR 140 13:
`empty ~ym bok Propofol l ntmvcnou~ Emul~ion balch 1)91:301 .
`
`lac (D a wson ct a l. , 1969) a nd we re diluted to a
`final t:atio n concentra tio n o f I n1M belo re usc.
`The p H quo ted is that o f the diluted buffer mea(cid:173)
`sured using a calibrated p H electro d e, and no t the
`p ublis hed va lue, which is no rmally incorrect due
`to the b uffer dilutio n facto r. We lhave previo usly
`used these buffers fo r the study o f trig lyceride
`emulsions and fo und tha t they d o no t give rise to
`d etecta ble e rro rs due lo specific ad sorptio n o f
`io ns.
`
`2.2.2. LiJ:hl d(/]i'auion
`Lig ht diffractio n was perfo rmed using a Co ul(cid:173)
`te r LS230 particle s ize ana lyser (Beckma n Coul(cid:173)
`te r, Luto n. U K) with the po la riza tio n inte nsity
`(' PI O S mo de') included in the analysis, a nd with
`an o ptical mod el using the refractive index o f soya
`o il. T he instrume nt was validated by the ma nu fa<.:(cid:173)
`turc r immedia tely prio r to the study. a nti several
`times during the trial. using polysty rene mic ro-
`
`216
`
`.1. /fan <'I a/.
`
`/nrermuioual .lmmw/of Plwmmcl!lllics 215 (200 /) 207 220
`
`Volume (%)
`
`·~! ~
`1~0 ~
`1-f-----< &~·1 I
`lil.._..._.~
`
`spheres (Co ulter Co rpo ra tio n , Mia mi, Flo rida.
`0.293 ~1111). Sa mple vo lumes o f 50- 200 ~d were
`diluted into the sample recirc ula to r until a P lDS
`intensity o f a pproximately 50'!1,, was achieved.
`Three sequential mea sureme nts (90 s each run)
`were mad e o n each ba tch.
`
`2.2.3. Optiml particle counting
`Particles larger than 1.5 ~1111 were counted with
`a PSS Nicomp Acc usizer 780 in the extinction
`m o de, in which the pa rticle s ize o f a dro plet is
`calculated fro m the lig ht blo ckage it produces in
`an o ptical sensor. The instrument was validated
`by
`the manufacturer immediately prio r to
`the
`study; calibra tio n was in the fo rm o r a calibra tio n
`rile whi<.:h is m a tched to the senso r. Pro pe r o pera(cid:173)
`ti o n o r
`the
`instrument wa s checked
`using
`polystyrene tnic rospheres (Duke Scientific. Pa lo
`Alto, Califo rnia) severa l times during the trial.
`The lower thresho ld was set to 1.7 pm: the mea(cid:173)
`surement time was 200 s w ith a now rate or
`60 ml/min. Fo r the unstressed emulsio ns a sample
`vo lume of 100 ~d was used but afte r the sta bility
`tests it was frequently nccessmy to predilute the
`samples to a void coincid ences be tween the numer(cid:173)
`o us large dro plets.
`
`2.2.4. Electrical =mw sensing
`D ro plet counting b y the e lectrica l zone m ethod
`was perfo rmed using a Coulter Z2 with a 50 ~·m
`a perture tube. This instrument p rovides a bsolute
`counts o f the number o f dro plets in a specified
`size range. ty pically fro m I to 10 ~un. The instru(cid:173)
`m ent was valid~tted by the lllcll1llfacturer immedi(cid:173)
`ately prio r
`to
`the study and
`the ca libra tio n
`c hec ked against po lystyrene microsphcrcs (Coul(cid:173)
`ter Corpo ratio n , Miami, Flo rida 9.932 pm ) sev(cid:173)
`eral times during the trial. The emulsio n was
`diluted to I :20 with isotonic saline, 40 ~tl of this
`mixture was added to 20 ml o f isoto nic saline in a
`co unting vial, a nd the dro plets in this mixture
`were counted w ith a 0.5 ml sample volume . This
`t:o rrespo nds to 50 nl o f th e origina l emulsio n
`being drawn uhro ugh the co unting o ririce. All
`samples were used immed ia te ly a fte r dilutio n a nd
`a ppropria te backgounds were subtracted .
`
`Exh. 1009
`
`

`
`J. llcm c•t a/.
`
`lntemlllimwl Joumctl 11{ Plwrman•IIIJI',\ 2 15 (2001) 207 :!20
`
`217
`
`2.2.5. Dy11cmJic li,::ht ~cauering (DLS)
`A Malvern 4700 DLS instrument was used to
`the
`:-aventge diameter
`(cllltllllants
`measure
`method) and droplet size distribution (analysis
`using CO T IN). 1 he in~trumenl oper<lles by
`measuring the diffusion coefficient or the droplets
`rrom the fluctuations in scattered light (Washing(cid:173)
`ton. 1992b} and is most sensitive to particles
`smaller than I ~1m. The instrument was validated
`against a poly~tyrcne microsphere standard (98
`nm. l ntert~u.:ial Dynamics Corporation. Portland.
`Oregon} every day prior to measurement. Samples
`or emtllsion were diluted into cylindrical counting
`cells until a count rate or 2 4 x 1 0~ counts per
`second was obtained. Datu were gathered ror 30 s
`counting periods with the correlator in linear se(cid:173)
`quenti<ll mode with automatic correlation time
`sclcdion. which normally resulted in a l'undamen(cid:173)
`tal sample time or 10 30 ps.
`
`2.2.6. p/1
`A Corning Model 7 pH meter was used with a
`combination glass SCE electrode to measure pH.
`The meter was checked and calibrated against
`standard pl-1 4 i CUll ami 7 ± I).() I butTers CScien(cid:173)
`tilic Laboratory Supplies. Nottingham). The elec(cid:173)
`trode was thoroughly rinsed. and its calibration
`checked. af'lcr every individual ~ample in order to
`avoid errors due to electrode oil contamination.
`
`2.1. 7. Ph rsiC'al appearmJe<'
`The pl;ysical appearance or the emulsions was
`recorded by microscopy (Olympus C H-2 micro(cid:173)
`scope). and by photography of' the scaled contain(cid:173)
`ers (Fuji DX7 digital camera) Hs necessary.
`
`2.3 .. s·whilily tests
`
`All testing was performed as :.oon as possible
`af'tcr the termination or the approprialC Slress test.
`All samples were tested in their original unopened
`containers on a single occasion and then di~­
`carded: no container was sampled more than
`once. l:::.m:h sample wm. evaluated by each instru(cid:173)
`ment in those cases where no f'ree oil was visible
`in the container. Samples showing a film or layer
`of oil visible to the naked eye without magnifica(cid:173)
`tion were considered to have broken and were not
`
`further measured. since we have found that the
`stati tical precision of such tests is poor. Further(cid:173)
`more. samples containing free oil normally cause
`subsequent exten~ive cleaning problems for the
`particle ~i.dng instru•nents.
`
`1.3.1. .%akin~
`Samples in the original unopened containers
`were ~ubjccted to shaking u ing a Burrell Model
`75 wrist-action shaker (Burrell Scientific. Pitts(cid:173)
`burgh} operating at 300 strokes/min at room tem(cid:173)
`perature (22 t 4°C). The shaking amplitude was
`set to its maximum value resulting in a bottle
`movement or approximately 8 cm. S<unples were
`shaken for 2. 4. 6, 8. I 0. 12 and 16 h and the
`position:.; or the vmiou~ batches was randomized
`on the shaker.
`
`2.3.2. Tflerlllal cycling
`Samples \Vcre stored in a Sanyo programm~tblc
`incubator (Model M I R 153. San yo Electric Co ..
`Japan) and subjected to a controlled thermal cycle
`or 8 h at 30°C followed by cooling to .t 8°C l'or
`16 h. Thi~ cycle was repeated on il daily basis and
`emulsion samples withdnmn at 7. 1-k and 21
`days. The heating cooling tunc or the incubator
`was approximately 30 min and its temperature
`precision was + 1°C. Thermal C)clcs were verified
`using a recording thermometer with K-type thcr(cid:173)
`mocou p le probe (I I anna I nst rum ems 11192804C
`with N/\MAS certified thennocouplc)
`
`2.3.3. Free:e tlta~t·
`Emulsions were lh.>Lcn in a convemional labo(cid:173)
`ratory freezer at - 20°C. They were <tgitatcd gen(cid:173)
`tly every )() min until completely solid and then
`stored rrozcn for a total or 8 h (i.e. inclutlinl!. the
`l'rcezing time) then th:nved at room tempcra7ure.
`
`3. Rcsull'i and di')cussicm
`
`The trial generated an exten-.ive array or data
`but ~pace prevent'> its complete presentation here.
`The complete data set is available electronically.
`Table I li'it'i the properties ol' the oriu.inal cmul(cid:173)
`-.ions. Samples from both manuf'acture;.s had sim(cid:173)
`ilar
`: -average
`diameter~ and
`sho"ed
`a
`comparahlc level of large droplets in all batches.
`
`Exh. 1009
`
`

`
`21R
`
`.1. //au 1!1 al.
`
`fllll!rlllllioual Joumalof Plmm wn•urics 115 (1001) 207 120
`
`However, Diprivan •· had a mean pH of 7.5 and
`Gensia Propofo l Emulsion had a mean pH of 5.3.
`Fig. 2 shows the zeta potentials ofrhe six batches
`or emulsions as a f'llnction of pH. T he trend is
`simila r to that previously reported fo r phospho(cid:173)
`lipid-stabilized pa renteral emulsions (Washington.
`1996) with a value of approximately -50 mY at
`pH 8 a nd a gntdual decline with decreasing pH.
`T his ~s due to changes in the io nization of the
`phospholipids; a sha rp surface pK., is not observed
`because the lecithin used is made up of a broad
`range o r compo nents with varying pK. Comparing
`the ze ta potential data to the emulsio n pH (Table
`I) indica tes that the mean zeta potential o r the
`emulsio n in the o rigina l container was - 50 mY in
`the case of Diprivan •· and - 40 mY in the case of
`Gensia Propofol Emulsion. This may not appear a
`pa rticula rly large difference and is fairly typical o r
`the level o r va riation observed in phospho lipid-sta(cid:173)
`bilized parenteral feeding emulsio ns, despite the
`difference in the fonTIUlation pH Of the emulsio ns.
`It sho uld be no ted tha t Diprivan'''' is formulated so
`that its 4elil po lenlinl doc,:s not va ry widely over its
`possible pH range, while the zeta po tential or
`Propo ro l lntravenOLIS Emulsio n can vary substan(cid:173)
`tially over its pH r<tnge (Fig. 2). As a result pH
`varia tions in Propofo l Intraveno us Emulsion will
`lead to much la rger changes in zeta po tential than
`co rrespo nding pH eha nges in Diprivan •·
`
`3. /. 1. Slwk i11g lest
`The results from the shaking test (DLS. Coulter
`Z2, Coulter LS230. PSS Accusizer) arc shown in
`Figs. 3 6. The :-average diameters of all the
`emulsions were simila r and did no t change signi fi(cid:173)
`cantly during the trial: all the variatio ns observed
`were within the limits of lo ng-term experimental
`erro r ( ± 5 nm ). All three batches of Propofo l
`Intra veno us Emulsion showed free oil a fter 8 12
`h shak ing. so DLS was not perfo rmed on these
`batches a fter these times. The a ppa rent insensitivity
`o r DLS to emulsion coalcscem;c is not unusual since
`this technique is only sensiti ve to dro plets smaller
`the\ I) approximately I pm. A small number o r laJ'gCI'
`droplets leads to a poorer qua lity of data filling but
`docs not generally in nuence the .:-average diameter
`despite the fact that such large d roplets contHin a
`significant mass of oil.
`
`The remaini111g instruments a re optimised fo r the
`detection of dro plets larger than approxima tely I
`~un, and they indica ted a rapid increase in the
`n umber of large droplets in Propofol Intravenous
`Emulsion with sha king. In contrast Diprivan "'
`showed no significant change over the dura(ion of
`t he study. Fig. 7 shows photomicrogra phs of all six
`batches of emu lsion after 8 h shaking. The a ppear(cid:173)
`ance of the Diprivan " samples was similar to that
`before shaking. while Propofo l Intravenous Emul(cid:173)
`sion showed a significan t number of large dro plets.
`After 16 h Propofol Intraveno us Emulsio n showed
`extensive free o il while Dipri van •· showed o nly a
`foam (Fig. 8). Foam formatio n is characteristic of
`emulsions in which no oil scpmation has occurred.
`since oil surface films invariably lead to rapid foam
`breakage (13ikcrman, 1973).
`
`3. 1.2. Thermal cycling
`None or the enwlsion batches showed a signifi(cid:173)
`cant change in either :-average droplet size o r large
`droplet count after 2 1 days thermal cycling. T ypical
`d ata (:-ctvcrage dia meter a nd Coulter Z2 large
`droplet count) are shown in Figs. 9 and I 0. respec(cid:173)
`'lively. The variatio ns in .:-average diameter arc
`typical of the lo ng-term precisio n o r the technique
`( ± 5 nm) and the va riations in the dro plet counts
`are consistent with the ra ndo m statistical variation
`in the droplet counting.
`
`3. I. 3. Free.:e- llw11'
`The behavio ur o r the emulsions under freeze(cid:173)
`thaw testing pa ralleled tha t o bserved during shak(cid:173)
`ing. with a single freeze thaw cycle causing a large
`increase in the droplet diameters of the Propofol
`Intraveno us Emulsion batches and only a very
`sma ll cha nge in the appeara nee or the Diprivan ''
`samples. Typical micrographs a rc shown in Fig. II .
`It is immediately obvious that the destabilizarion
`ca used by freeze- thawing was far more extensive
`than that ca used by shetking. since a large rraction
`or the Propo f'o l Intraveno us Emulsio n appeared to
`be made up of large droplets of broken emulsion.
`This is in contrast to the coalescence caused by
`shaking, and provides some insight into the mech(cid:173)
`anisms of destabiliza tion. In the case o r freeze(cid:173)
`thawing, the majo rity o r the oil droplets arc
`compressed together between the advancing ice
`
`Exh. 1009
`
`

`
`J. lfttll t'l ul.
`
`fllf('fllltlionul Journal t~/ 1'/tm·mun•tlfiC"'" :! 15 (:!(}(}I) :!07 220
`
`219
`
`crystals as the con

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket